Department of Urology, University Hospital, Curitiba 80420-011, Brazil
Mini Review
DNA Hypomethylation in Prostate Cancer is Consistent
Author(s): Daniela Gerovska*
With approximately 1.4 million men diagnosed with prostate cancer each year around the world, PCa remains a terrifying threat to life and a
source of devastating morbidity. Increased prostate-specific antigen screening and improved treatments have resulted in a significant decrease
in age-specific PCa mortality in recent decades. Nonetheless, upcoming, enhanced PSA screening recommendations highlight an increasing
disparity between the benefit and harm of current diagnosis/prognosis and application of radical treatment standards. To alleviate this tense
situation, new powerful diagnostic and prognostic tools are unquestionably required. They should enable a more reliable early assessment of the
impending threat, allowing for timely adjusted and personalised therapy and monitoring. We present here a basic study on an epigenetic screening
method using Methylated .. Read More»
DOI:
10.37421/2157-7099.2022.13.667
Journal of Cytology & Histology received 2334 citations as per Google Scholar report